Translation and validation new criteria and scale of symptoms severity of Fibromyalgia for Portuguese of Brazil

• Grant number: 13/02437-7
• Support Opportunities: Scholarships in Brazil - Scientific Initiation
• Start date: April 01, 2013
• End date: March 31, 2014
• Field of knowledge: Health Sciences - Physiotherapy and Occupational Therapy
• Principal Investigator: Amélia Pasqual Marques
• Grantee: Anna Maria de Barros Gonçalves
• Host Institution: Faculdade de Medicina (FM). Universidade de São Paulo (USP). São Paulo , SP, Brazil

Abstract

Fibromyalgia is a rheumatic syndrome characterized by chronic widespread musculoskeletal pain, associated with fatigue, sleep disturbances, morning stiffness, anxiety, stress, and dyspnea in some cases. In Brazil, fibromyalgia is the second most common rheumatologic disorder, after osteoarthritis. Is more prevalent in women, especially in the age group between 35 and 60 years. Over time, a number of criticisms have been made to the criteria of the American College of Rheumatology (ACR) of 1990. First, it became clear that the count of the location and intensity of pain at tender points, was rarely performed in primary care, and when practiced, was performed incorrectly. There is still the difficulty of assessing the clinical improvement of patients since these may improve symptoms, decrease the sensitive points and stop being classified as individuals with fibromyalgia. The new criteria try to classify the patient as to the severity of symptoms and at any time can finish the fibromyalgia classification if present clinical improvement. This criterion is aimed at use in primary care and uses in the follow-up of patients longitudinally. This work aims to translate and validate the new Fibromyalgia diagnostic criteria proposed by the American College of Rheumatology (ACR) in 2010 to the Portuguese-Brazilians. The work will be performed in two stages: translation; and reliability and reproducibility of new criteria for the Portuguese-Brazilian. There will also be evaluating individuals with fibromyalgia in order to compare 1990 with 2010 criteria. Algometer will be used and the Visual Analog Scale (VAS) to assess pain and Fibromyalgia impact questionnaire (FIQ). Any statistical analysis will be performed to a 0.05 significance level. (AU)